InsiderTrades

Form 4 for TMO Thermo Fisher Scientific

Accepted 2026-02-27 00:00:00 ET · period of report 2026-02-25 · accession 0000097745-26-000029 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2026-02-27 2026-02-25 TMO CASPER MARC N COB, CEO, Dir A - Grant $0.00 +14.8K 128.6K +13% $0
D 2026-02-27 2026-02-25 TMO CASPER MARC N COB, CEO, Dir A - Grant $0.00 +32.1K 32.1K New $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2026-02-25 A A 7,515 $0.00 121,277.29 D — — (F1) Shares represent a performance-based restricted stock unit award granted on February 19, 2025. The Company's Compensation Committee determined on February 25, 2026, that the performance criteria related to this award were satisfied. One-third of the shares vest on February 28, 2026 and 2027. The remaining one-third will vest on February 28, 2028, and is subject to adjustment (positive or negative) for long-term performance which is based on the comparison of the Company's total shareholder return compound annual growth rate ("CAGR") to the total shareholder return CAGR of each of the companies in the peer group, as specified within the award agreement, over the measurement period starting on January 1, 2025, through to December 31, 2027.
2 Common Common Stock 2026-02-25 A A 7,333 $0.00 128,610.29 D — —
3 Derivative Stock Option (Right to Buy) 2026-02-25 A A 32,109 $0.00 32,109 D $513.68 · — to 2036-02-25 32,109 Common Stock (F4) The option vests in four equal annual installments beginning on February 28, 2027.